{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011282","form_type":"8-K","ticker":"STRO","cik":"0001382101","company_name":"SUTRO BIOPHARMA, INC.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.423706+00:00","generated_at":"2026-06-25T03:51:34.606742+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Sutro Biopharma stockholders elect four Class I directors, approve say-on-pay and auditor at 2022 annual meeting","bullets":["Four Class I directors elected: Michael Dybbs, John G. Freund, Heidi Hunter, Jon Wigginton, each to serve three-year terms.","Ratification of Ernst & Young as independent auditor for FY2022 approved with 43,752,354 votes for, 11,569 against.","Advisory vote on named executive officer compensation (say-on-pay) approved with 40,921,442 for, 759,278 against.","Stockholders selected one-year frequency for future advisory votes on executive compensation; board adopts annual frequency."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011282","json":"https://secwatch.observer/filing/0000950170-22-011282.json","markdown":"https://secwatch.observer/filing/0000950170-22-011282.md","text":"https://secwatch.observer/filing/0000950170-22-011282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382101/000095017022011282/0000950170-22-011282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382101/000095017022011282/stro-20220606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:51:34.606742+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}